ES8603850A1 - Un procedimiento para la preparacion de nuevos derivados de benzotiazolina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de benzotiazolina.

Info

Publication number
ES8603850A1
ES8603850A1 ES539066A ES539066A ES8603850A1 ES 8603850 A1 ES8603850 A1 ES 8603850A1 ES 539066 A ES539066 A ES 539066A ES 539066 A ES539066 A ES 539066A ES 8603850 A1 ES8603850 A1 ES 8603850A1
Authority
ES
Spain
Prior art keywords
arylbenzothiazoline
derivatives
treating angina
angina cordis
cordis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539066A
Other languages
English (en)
Spanish (es)
Other versions
ES539066A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of ES539066A0 publication Critical patent/ES539066A0/es
Publication of ES8603850A1 publication Critical patent/ES8603850A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES539066A 1983-12-27 1984-12-26 Un procedimiento para la preparacion de nuevos derivados de benzotiazolina. Expired ES8603850A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58251934A JPS60139679A (ja) 1983-12-27 1983-12-27 ２−アリ−ルベンゾチアゾリン誘導体

Publications (2)

Publication Number Publication Date
ES539066A0 ES539066A0 (es) 1986-01-01
ES8603850A1 true ES8603850A1 (es) 1986-01-01

Family

ID=17230142

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539066A Expired ES8603850A1 (es) 1983-12-27 1984-12-26 Un procedimiento para la preparacion de nuevos derivados de benzotiazolina.

Country Status (8)

Country Link
US (1) US4547513A (enExample)
JP (1) JPS60139679A (enExample)
KR (1) KR910004432B1 (enExample)
DE (1) DE3446992A1 (enExample)
ES (1) ES8603850A1 (enExample)
FR (1) FR2557109B1 (enExample)
GB (1) GB2152046B (enExample)
IT (1) IT1179549B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62221679A (ja) * 1986-03-19 1987-09-29 Santen Pharmaceut Co Ltd ベンゾチアゾリン誘導体
JPH066581B2 (ja) * 1986-03-19 1994-01-26 参天製薬株式会社 フエノキシアルキルアミン側鎖を有するベンゾチアゾリン誘導体
US5229398A (en) * 1990-02-27 1993-07-20 Adir Et Compagnie Aminomethylpiperidine compounds
EP1496053B1 (en) 2002-03-29 2012-06-20 Santen Pharmaceutical Co., Ltd. Kappa-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative
EP1642590A4 (en) * 2003-07-04 2009-05-13 Santen Pharmaceutical Co Ltd MEANS TO INHIBIT THE DEGRADATION OF THE PAIN LIMIT
US7642274B2 (en) 2003-07-04 2010-01-05 Santen Pharmaceutical Co., Ltd. Inhibitor of pain threshold decrease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB825016A (en) * 1956-11-02 1959-12-09 Crookes Lab Ltd Therapeutic derivatives of aryl-benzthiazoles
US3720683A (en) * 1970-09-02 1973-03-13 Squibb & Sons Inc 2-phenyl-3-acylbenzothiazolines and their oxides
JPS5846079A (ja) * 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類

Also Published As

Publication number Publication date
GB8432034D0 (en) 1985-01-30
IT1179549B (it) 1987-09-16
ES539066A0 (es) 1986-01-01
IT8424269A0 (it) 1984-12-27
KR910004432B1 (ko) 1991-06-27
KR850004491A (ko) 1985-07-15
US4547513A (en) 1985-10-15
IT8424269A1 (it) 1986-06-27
GB2152046A (en) 1985-07-31
GB2152046B (en) 1987-06-03
JPH0545587B2 (enExample) 1993-07-09
DE3446992A1 (de) 1985-07-04
JPS60139679A (ja) 1985-07-24
FR2557109A1 (fr) 1985-06-28
FR2557109B1 (fr) 1987-09-04

Similar Documents

Publication Publication Date Title
DE3584393D1 (de) 1-heteroaryl-4-aryl-pyrozolin-5-one.
PT84144A (en) Process for preparing heterocyclic sulphonamides useful as antiallergic and antithrombotic agents
SE8503922L (sv) Analgetiska 1,2-bensisotiazol-3-ylpiperazin-derivat
AR240909A2 (es) Derivados de 2-(2'-alquilbenzoil) -1,3-ciclohexanodiona, composicion que los comprende y procedimiento para prepararlo"
DE3464132D1 (de) Naphthoquinone derivatives
ATE25078T1 (de) 2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
DK169984A (da) Pyrimidinderivater
ZA874046B (en) Antiallergy and antiinflammatory agents
GB8828831D0 (en) Substituted imidazole derivatives & their preparations & use
ES8601963A1 (es) Un procedimiento para preparar (1h-tetrazol-5-il)-2(1h)-quinolonas
DE3779187D1 (de) 2-trifluormethyl-benzimidazole.
DE3876312D1 (de) (azolyl-vinyl)-phenol-alkenylether.
BR9801448B1 (pt) compostos heterocÍclicos, processo para sua preparaÇço e composiÇÕes farmacÊuticas contendo os mesmos.
ES8604132A1 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquiltiofenil)-2-amino-1,3-propandiol
ES8602717A1 (es) Procedimiento para la preparacion de derivados de tiazolidina.
AU571314B2 (en) Monosilylated aminophenylethylamine derivatives
ES509535A0 (es) "un metodo de preparar una 4-ariloxi-1,2,3,4-tetrahidroisoquinoleina".
DE69023045D1 (de) Carboxamidderivate.
DK518888D0 (da) Heteroarylcarboxamidderivater
TW333525B (en) New perhydroisoindole derivatives, their preparation and the pharmaceutical compositions which contain them the invention relates to perhydroisoindole derivatives of general formula (I), and their salts when they exist advantageously as neurokinin A antagonists.
NO890531L (no) 3,4-dihydro-2-alkyl-3-okso-n-aryl-2h-(1)benzotieno(3,2-e)-1,2-tiazin-4-karboksamid-1,1-dioksyder.
NO860742L (no) Fungicid middel for konservering av trevirke.
ES509194A0 (es) Procedimiento para la preparacion de una nueva tiovinil-3 cefalosporina.
DE3775939D1 (en) Elektrophotographischer photorezeptor.
FR2508909B1 (enExample)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201